Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:32 PM
Ignite Modification Date:
2025-12-24 @ 9:32 PM
NCT ID:
NCT00839332
Eligibility Criteria:
Inclusion Criteria:
* Diagnosed with cancer that is metastatic and/or advanced during Phase 1
* Diagnosed with pancreatic cancer that is metastatic and not amenable to surgery
* Must be at least 18 years of age
* Adequate hematological, liver, and renal functions
* Eastern Cooperative Oncology Group (ECOG) status of 0 to 2
Exclusion Criteria:
* Known hypersensitivity to gemcitabine
* Pregnant or lactating females or refusal to use medically approved contraceptive precautions
* Had prior treatment with radiotherapy involving more than 25% of marrow producing area
* Have received treatment in the last 30 days with a drug which has not received regulatory approval for any indication at the time of study entry
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
85 Years
Study:
NCT00839332
Study Brief:
Protocol Section:
NCT00839332